Apop Imaging
Apop Imaging will launch its patented CalRexin globally (> $450 mio/year market), to provide researchers with powerful new tools to image in vivo cell events.
- Stage Full Product Ready
- Industry Biotechnology
- Location North Melbourne, Victoria, Australia
- Currency AUD
- Founded October 2016
- Employees 2
- Incorporation Type C-corp
- Website apopimaging.com.au
Company Summary
Apop Imaging Pty Ltd is a Melbourne based biotech start up company founded to bring novel imaging tools to a global biomedical research market. Apop Imaging was registered in October 2016 and completed a seed funding round led by Geelong and Melbourne Angels in 2018. The high calibre board and management team has secured key partnerships for R&D, and the company is on track to commercialise its first product at the end of 2019.
Team
-
CSO
Inventor of the concept and patent initiator, Peter's deep experience has led to the product 'Calrexin'.
-
CEO
Phil has 25 years leading in the pharma and biotech industries, running everything from start-ups to Billion Euro global pharmaceutical franchises. Phil has a BSc. a grad Dip Psych, is a GAICD and has had executive education on 3 continents. Phil has deep experience in commercialisation of complex products in highly scientific markets, and brings a strong fiscal discipline paired with a keen understanding of behavioural marketing and leadership
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.